Results of photodynamic therapy in Barrett's esophagus: A review

Canadian Journal of Gastroenterology

Volumn 13, Issue 5, 1999, Pages 393-396

  Overholt, Bergein F ^a,b  

^a THOMPSON CANCER SURVIVAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Barrett's esophagus; Esophagectomy; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; LUGOL; OMEPRAZOLE; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BIOPSY; CLINICAL TRIAL; COLUMNAR EPITHELIUM; CONFERENCE PAPER; DISEASE ASSOCIATION; DYSPHAGIA; DYSPLASIA; ELECTROCOAGULATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MUCOSA; HEART ATRIUM FIBRILLATION; HUMAN; LASER SURGERY; META ANALYSIS; NEODYMIUM LASER; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPECTRAL SENSITIVITY; SQUAMOUS EPITHELIUM; STOMACH ACID SECRETION; SUNBURN; SURGICAL MORTALITY; TREATMENT OUTCOME; TUMOR RECURRENCE;

EID: 0033021201     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/692453     Document Type: Conference Paper

References (44)

1. Barrett N. Chronic peptic ulcer of the oesophagus and esophagitis. Br J Surg 1950;38:175-82.
2. Allison PR, Johnstone AS. The oesophagus lined with gastric mucous membrane. Thorax 1953;8:87-101.
3. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
4. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
5. Hamilton SR, Smith RRL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-12.
6. Sjogren RW Jr, Johnson LF. Barrett's esophagus: A review. Am J Med 1983;74:313-21.
7. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1987;315:362-71.
8. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk. Gastroenterology 1984;87:927-33.
9. Burbige EJ, Radigan JJ. Characteristics of the columnar-lined (Barrett's) esophagus. Gastrointest Endosc 1979;24:133-6.
10. Spechler SJ. The columnar-lined esophagus. History, terminology, and clinical issues. Gastroenterol Clin North Am 1997;26:455-66.
11. Cameron AJ, Sinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus: Comparison of population-based and autopsy findings. Gastroenterology 1990;99:918-22.
12. Polopalle SC, McCallum RW. Barrett's esophagus: Current assessment and future perspectives. Gastroenterol Clin North Am 1990;19:733-44.
13. Reid BJ, Weinstein WM, Lewin KH, et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988;94:81-90.
14. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993;105:40-50
15. Naef AP, Savar M, Ozzello L. Columnar-lined lower esophagus: An acquired lesion with malignant predisposition. J Thorac Cardiovasc Surg 1975;70:826-35.
16. Menke-Pluymers MBE, Schoute NW, Mulder AH, Hop WCJ, van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992;33:1454-8.
17. Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991;161:97-9.
18. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high grade dysplasia: An indication for esophagectomy? Ann Thorac Surg 1992;54:199-204.
19. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
20. Deviere J, Buset M, Dumonceau J-M, Rickaert F, Cremer M. Regression of Barrett's esophagus with omeprazole. N Engl J Med 1989;320:1497-8.
21. Malesci A, Savarino V, Zentilin P, et al. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 1996;44:700-5.
22. Gore S, Healy CJ, Sutton R, Shepherd NA, Wilkinson SP. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993;7:623-8.
23. Sharma P, Sampliner RE, Camargo E. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997;92:582-5.
24. Igbal TH, Neumann CS, Cooper BT. Omeprazole treatment of patients with Barrett's oesophagus. Gut 1993;34(Suppl):S19.
25. Sampliner RE, Garewal HS, Fennerty MB, Aicken M. Lack of impact of therapy on extent of Barrett's esophagus in 67 patients. Dig Dis Sci 1990;35:93-6.
26. Sampliner RE, Mackel C, Jennings D, Greski-Rose P. Effects of up to 3 years of high dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994;89:1844-8.
27. Brand DL, Yivisaker JT, Gelfand M, Pope CR. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery. N Engl J Med 1980;302:844-8.
28. Williamson WA, Ellis FH, Gibb SP. Effect of anti-reflux operation on Barrett's mucosa. Ann Thorac Surg 1990;49:537-42.
29. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995;82:806-10.
30. Sampliner RE. Antireflux surgery and Barrett's esophagus regression: Wheel of fortune or to tell the truth? Am J Gastroenterol 1991;86:645-6.
31. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Gastointest Endosc 1992;38:619-22.
32. Brandt LJ, Blansky RL, Kauvar DR. Repeat laser therapy of recurrent Barrett's epithelium: success with anacidity. Gastrointest Endosc 1995;41:267. (Lett)
33. Sampliner RE, Hixson LJ, Fennerty B, Garewal HS. Regression of Barrett's esophagus by laser ablation in an anacid environment. Dig Dis Sci 1993;38:365-8.
34. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowiu WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993;104:1686-91.
35. Sampliner RE, Fennerty B, Garewai HS. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results. Gastrointest Endosc 1996;44:523-5.
36. Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H. Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997;41:281-4.
37. Overholt BF, Panjehpour M, Teffetellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 1993;39:73-6.
38. Overholt BF, Panjehpour M. Barrett's esophagus: Photodynamic therapy for ablation of dysplasia, reduction of specialized mucosa and treatment of superficial esophageal cancer. Gastrointest Endosc 1995;42:64-70.
39. Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995;42:59-63.
40. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol 1996;91:1719-23.
41. Barr H, Shepherd NA, Robert DJH, et al. Eradication of high grade dysplasia in columnar lined (Barrett's) esophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 1996;348:584-5.
42. Overholt BF, Panjehpour M. Photodynamic therapy for Barrett's esophagus. Gastroenterol Clin North Am 1997;7:207-20.
43. Overholt BF, Panjehpour M, Haydek J. Photodynamic therapy for Barrett's esophagus: follow up in 100 patients. Gastrointest Endosc 1999;49:1-7.
44. Gossner L, Stolte M, Sroka R, Rick K, Hahn EGF, Ell C. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998;114:448-55.